DF/HCC Breast SPORE Renewal RFA

November 22, 2022

The DF/HCC SPORE in Breast Cancer is planning a 2023 competitive grant renewal application and is seeking potential projects that are focused on exceptional investigator-initiated research that will contribute to improved prevention, early detection, diagnosis, and treatment of breast cancer.  SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant of 5 years. 

The due date for submitting the project application is Monday, January 9th by 5:00 pm. 

Please see the RFA below for additional details and do hesitate to reach out with any questions.  

Thank you. 

Nancy Lin, MD
Dana-Farber Cancer Institute

Kornelia Polyak, MD, PhD
Dana-Farber Cancer Institute

Geoffrey Shapiro, MD, PhD
Dana-Farber Cancer Institute

Related files